Does HALOPERIDOL Cause Mobility decreased? 25 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Mobility decreased have been filed in association with HALOPERIDOL (Haloperidol). This represents 0.2% of all adverse event reports for HALOPERIDOL.
25
Reports of Mobility decreased with HALOPERIDOL
0.2%
of all HALOPERIDOL reports
0
Deaths
14
Hospitalizations
How Dangerous Is Mobility decreased From HALOPERIDOL?
Of the 25 reports, 14 (56.0%) required hospitalization, and 3 (12.0%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for HALOPERIDOL. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does HALOPERIDOL Cause?
Drug ineffective (1,771)
Neuroleptic malignant syndrome (1,244)
Off label use (1,136)
Toxicity to various agents (872)
Extrapyramidal disorder (838)
Somnolence (712)
Intentional self-injury (636)
Drug interaction (596)
Weight increased (583)
Tremor (579)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which HALOPERIDOL Alternatives Have Lower Mobility decreased Risk?
HALOPERIDOL vs HALOPERIDOL DECANOATE
HALOPERIDOL vs HECTOROL
HALOPERIDOL vs HEMIN
HALOPERIDOL vs HEPARIN
HALOPERIDOL vs HEPARIN\SODIUM